PI
CRL icon

PFS Investments’s Charles River Laboratories CRL Stock Holding History

PFS Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.31M Sell
15,739
-211
-1% -$42K 0.05% 273
2023
Q1 		$3.13M Buy
15,950
+63
+0.4% +$14.3K 0.05% 265
2022
Q4 		$3.46M Sell
15,887
-606
-4% -$132K 0.06% 233
2022
Q3 		$3.25K Buy
16,493
+2,490
+18% +$538K 0.06% 222
2022
Q2 		$3M Buy
14,003
+2,418
+21% +$591K 0.06% 241
2022
Q1 		$3.29M Buy
11,585
+2,876
+33% +$887K 0.06% 235
2021
Q4 		$3.28M Buy
+8,709
New +$3.38M 0.06% 233

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return